AbbVie turns to newer immunology drugs as blockbuster Humira faces lower-cost competition
July 25, 2023 at 10:41 AM EDT
Investors look for signs that Skyrizi, Rinvoq can take the baton as Humira sales falter
|
||||||||||||
|
||||||||||||
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map |